Navigation Links
Spectral to bring anti-sepsis therapy to the U.S. market
Date:9/23/2008

TORONTO, Sept. 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: SDI) today announced that it has agreed to key terms with Toray Industries Inc. of Japan to obtain the exclusive development and commercial rights in the U.S. for Toraymyxin(TM), a therapeutic for the treatment of sepsis that removes endotoxin from the bloodstream. Under the terms of the agreement, the Company will seek FDA approval for a combined product for the treatment of severe sepsis that will include Toraymyxin(TM) and Spectral's Endotoxin Activity Assay (EAA(TM)), the only FDA cleared diagnostic for the measurement of endotoxin. The conclusion of final commercial agreements is subject only to the completion of due diligence by Spectral and the determination of an approved clinical development pathway with the U.S. FDA.

"Toraymyxin(TM) is marketed in Japan and Europe and has been used to treat more than 50,000 sepsis patients safely and effectively. Spectral's EAA (TM) can identify patients that will benefit from Toraymyxin(TM) and monitor the effects of the treatment," said Dr. Paul Walker, President and CEO of Spectral. "This combination of the EAA(TM) diagnostic and the Toraymyxin(TM) therapeutic has been utilized by clinicians in Europe since November 2007 and has demonstrated the potential to lead to a significant reduction in mortality, as documented in the findings presented at the 28th International Symposium on Intensive Care and Emergency Medicine in March 2008. We believe that this combined treatment can fulfill a major unmet need for the approximately 100,000 patients that develop severe sepsis or septic shock in the U.S. each year."

"The business alliance with Toray and the specific combination of our approved diagnostic with their therapeutic device represent a significant market opportunity for Spectral," said Anthony Businskas, Spectral's Executive Vice-President and CFO. "Over the coming months, we expect to complete our due diligence and discuss t
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
2. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
3. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
4. Spectral and Toray expand collaboration to include new geographic territories
5. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
6. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
7. Spectral announces 2007 financial results
8. Spectral appoints Anthony Bihl to Board of Directors
9. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
10. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
11. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  Decision Resources Group finds ... and Mexico ... several newly approved agents, the anticipated label extension ... the launch of emerging biologics will substantially increase ... the emerging IL-5 inhibitors will introduce a new dynamic ...
(Date:8/21/2014)... 2014 Pursuit Solutions ( http://www.pursuit-solutions.com ... and services for Life Sciences sales and marketing ... of New Commercial Sales Models” by Peter Robinson, ... The article examines some innovative models used to ... tested in the pharmaceutical market. Robinson grades the ...
(Date:8/20/2014)... 20, 2014 Clintrax Global, Inc., a ... Raleigh, NC , recently announced ... Vice President of Administration. As ... corporate processes, including their alignment with company objectives ... worked as an HR executive, specializing in needs ...
(Date:8/20/2014)... Livermore, California (PRWEB) August 20, 2014 ... to develop and apply the most complete climate ... challenging and demanding climate change issues. , Eight ... combining forces with the National Center for Atmospheric ... in the new effort. Other participating national laboratories ...
Breaking Biology Technology:Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2Clintrax Global, Inc. Announces Addition to Executive Team 2New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3
... April 23 ImaRx Therapeutics,Inc. (Nasdaq: IMRX ... an agreement,with Abbott Laboratories pursuant to which it ... promissory note with Abbott issued in,connection with its ... to,the urokinase assets, including the remaining inventory of ...
... PHILADELPHIA, April 23 BioNanomatrix, Inc. today,announced that ... honored at the,14th Annual Ben Franklin Emerging Business ... Management Team category, competing with a,strong group of ... executive officer Dr. Michael Boyce-Jacino accepted the,award on ...
... Calif., April 23 SectorWatch.biz announces the,availability ... news and driving,markets today within the biotechnology ... on the aforementioned equities and the,opportunity for ... on the,subject and sector., Investors can ...
Cached Biology Technology:ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3BioNanomatrix Named 'Best Management Team' at the 2008 Ben Franklin Emerging Business Awards 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 3
(Date:8/20/2014)... POINT ROBERTS, Washington , August 20, 2014 ... Role in Addressing Security Concerns in the Payment Industry? ... source covering leading sectors including biometrics, issues commentary from analysts ... Jason Peaslee , Managing Partner at Thrive Analytics, ... Pereira , CEO of NXT-ID, Inc. (OTCBB: NXTD) ( OTCQB:NXTD ...
(Date:8/19/2014)... caesarean section rate, suggests a new commentary published today ... Obstetrics and Gynaecology (BJOG) . , China has one ... Of 16 million babies born in 2010, approximately half ... known, the current Chinese language literature on caesarean rates ... to 58%. However, before the 1980s, the caesarean rate ...
(Date:8/19/2014)... used in supermarkets to encourage healthier spending habits? A ... that very question by tracking the purchasing records in ... to rate the nutritional value of foods for sale. ... David Just, PhD, and Brian Wansink PhD, author of ... over 150 Hannaford Supermarkets in the Northeastern United States ...
Breaking Biology News(10 mins):Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 3Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 4Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 5Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 6Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 7Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3
... United Nations Intergovernmental Panel on Climate Change (IPCC) have warned ... achieve a stable climate on our planet by the end ... coming decades must be curbed before the emissions can be ... CO2 emissions that can be tolerated globally by the end ...
... genetically modified crops, according to new research funded by ... A group at the Open University, led by Professor ... what large-scale, commodity farmers not those mainly involved ... know how consumers, governments and the food industry regard ...
... University of Nottingham could have a major impact on the ... to stay in work. Back pain is one of ... In 2004-5 approximately 34,000 people in the East Midlands suffered ... caused or made worse by their current or past work. ...
Cached Biology News:ETH Zurich competence center ESC introduces energy strategy 2ETH Zurich competence center ESC introduces energy strategy 3What farmers think about GM crops 2Helping back pain sufferers to stay in work 2
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Dendritic Cells...
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Biology Products: